Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-01-05 @ 11:57 AM
Study NCT ID:
NCT01114503
Status:
TERMINATED
Last Update Posted:
2020-10-30
First Post:
2010-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Sponsor:
Organization: